Alkem Laboratories Ltd (NSE:ALKEM) Share Price

Company Profile

Business description
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
Contact
Senapati Bapat Marg
Alkem House, Devashish Building
Lower Parel
MumbaiMH400 013
IND
T: +91 2239829999
https://www.alkemlabs.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
21,057

Recommended

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Matt Wacher | 21 February 2025

We’ve upgraded our fair value estimate for 29 companies, or 40% of those that have reported thus far.

Lochlan Halloway | 20 February 2025

Our analysts think these companies are undervalued and their shares appear to have the stamp of approval from highly rated managers.

Joseph Taylor | 20 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,570.90	30.80	-0.36%
CAC 40	8,154.51	31.93	0.39%
DAX 40	22,287.56	27.09	-0.12%
Dow JONES (US)	43,493.51	683.14	-1.55%
FTSE 100	8,659.37	3.60	-0.04%
HKSE	23,477.92	900.94	3.99%
NASDAQ	19,644.06	318.30	-1.59%
Nikkei 225	38,776.94	98.90	0.26%
NZX 50 Index	12,752.58	127.78	-0.99%
S&P 500	6,036.09	81.43	-1.33%
S&P/ASX 200	8,296.20	26.60	-0.32%
SSE Composite Index	3,379.11	28.33	0.85%